Brain's Ability to Recognize Glucose Offers New Insights for Treating Obesity and Diabetes

Scientists have discovered that the brain can specifically recognize glucose through a dedicated gut-brain circuit. This breakthrough opens new possibilities for targeted treatments for obesity and diabetes by understanding nutrient-specific neural responses.
A groundbreaking study by researchers at KAIST has revealed that the brain can directly and selectively identify glucose among various nutrients absorbed in the gut. This discovery challenges the traditional understanding that the brain merely detects overall caloric intake and instead shows that it can distinguish specific nutrients in real time, notably glucose, which is vital for energy metabolism and brain function.
The research team, including Professor Greg S.B. Suh, in collaboration with other experts, identified a specialized gut-brain circuit that enables animals in a hungry state to detect and prefer glucose in the small intestine. Prior studies had suggested that caloric content influences hunger regulation via hypothalamic neurons, but the existence of a nutrient-specific recognition pathway was unconfirmed.
Using advanced techniques like optogenetics, the scientists injected various nutrients—D-glucose, L-glucose, amino acids, and fats—directly into the small intestines of mice. They observed that specific neurons in the paraventricular nucleus (PVN) of the hypothalamus responded uniquely to D-glucose, but not to other sugars or nutrients. These glucose-responsive neurons, known as corticotropin-releasing factor (CRF) neurons, are central to the body's stress response via the hypothalamic-pituitary-adrenal (HPA) axis.
The signaling pathway for glucose detection was found to involve transmission from the small intestine through the spinal cord to the PBNdl of the brain, distinct from the vagus nerve pathway used for amino acids and fats. When the researchers inhibited these CRF neurons in fasting mice, it eliminated their preference for glucose, proving the circuit's critical role in nutrient-specific appetite.
This innovative research builds upon earlier work using fruit flies, where researchers identified glucose-detecting neurons. In mammals, they demonstrated that neurons in the hypothalamus respond rapidly to glucose influx, guiding nutrient-specific feeding behavior.
The findings suggest that energy metabolism and homeostasis are controlled by specialized neural circuits that can distinguish and respond to specific nutrients, opening new avenues for treating metabolic diseases like obesity and diabetes. Future research aims to uncover similar brain circuits responsible for sensing other vital nutrients like amino acids and fats.
The study emphasizes the sophisticated neural mechanisms controlling appetite and offers promising targets for developing more effective therapies for metabolic health issues.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How Blood and Ultrasound Biomarkers Improve Prediction of Liver Transplant Outcomes
Recent studies reveal how blood and ultrasound biomarkers can predict outcomes after liver transplantation, aiding in personalized patient care and improving survival rates.
Promising Advances in Zika Virus Vaccine Testing Using Mice Models
A new Zika virus vaccine developed using virus-like particles shows promising results in mice, offering protection against brain and testicular damage and advancing Zika prevention efforts. Source: https://medicalxpress.com/news/2025-08-vaccine-zika-virus-results-mice.html
Experimental Nanobody Showcases Promising Results in Treating Psoriatic Arthritis
A new nanobody-based treatment shows significant improvements in joint and skin symptoms of psoriatic arthritis in early clinical trials, offering hope for better management of the disease.
Novel Mechanism Linking Mitochondrial Dysfunction to Obesity-Related Insulin Resistance
Scientists have discovered a specific mitochondrial dysfunction in the liver that plays a key role in obesity-related insulin resistance and type 2 diabetes, opening new avenues for targeted therapies.



